Pages with the most revisions

From LipidomicsWiki

Jump to: navigation, search

Showing below up to 491 results starting with #1.

View (previous 500) (next 500) (20 | 50 | 100 | 250 | 500)

  1. Lipid Conference Calendar ‎(201 revisions)
  2. Proposal for lipid MS nomenclature ‎(175 revisions)
  3. Main Page ‎(173 revisions)
  4. LipidomicNet-ENOR joint workshop ‎(163 revisions)
  5. Beneficiaries ‎(139 revisions)
  6. Project Management ‎(120 revisions)
  7. Eicosanoid determination - Masoodi et al. ‎(117 revisions)
  8. Steering Committee Meeting - 11/2008 ‎(117 revisions)
  9. Eicosanoid determination - Yue et al. ‎(111 revisions)
  10. Lipid mass spectrometry ‎(103 revisions)
  11. Announcement board ‎(100 revisions)
  12. Sphingosine-1-phosphate - LC-MS/MS - Schmidt et al. ‎(95 revisions)
  13. LipidomicNet publications ‎(93 revisions)
  14. Meeting Plan ‎(93 revisions)
  15. Sphingosine-1-phosphate - LC-MS/MS - Berdyshev et al. ‎(91 revisions)
  16. TIC 2013 Tbilisi International Conference 2013 ‎(90 revisions)
  17. Events:Internal ‎(86 revisions)
  18. Eicosanoid determination - Harkewitz et al. ‎(84 revisions)
  19. Task Force VIII ‎(70 revisions)
  20. Ceramide - ESI-MS/MS - Liebisch et al. ‎(67 revisions)
  21. Glycosphingolipids ‎(66 revisions)
  22. Task Force Overview ‎(64 revisions)
  23. Steering Committee Meeting - 07/2009 ‎(64 revisions)
  24. Ceramides (SP02) ‎(63 revisions)
  25. LC-MS ‎(61 revisions)
  26. Sphingosine/Sphinganine - LC-MS/MS - Lieser et al. ‎(60 revisions)
  27. Workshop - 2009/10 ‎(57 revisions)
  28. Steering Committee Meeting - 01/2011 ‎(56 revisions)
  29. Prostaglandins (FA0301) ‎(54 revisions)
  30. LipidomicNet Final Meeting - 10/2012 ‎(52 revisions)
  31. Task Force I ‎(51 revisions)
  32. Sphingosine-1-phosphate - LC-MS/MS - Bielawski et al. ‎(47 revisions)
  33. Fluorescence Microscopy (High-Content Imaging) SPP for the analysis of lipid droplets for the Discovery-1 automated microscope of Molecular Devices ‎(45 revisions)
  34. Lipid standards needed in LipidomicNet ‎(45 revisions)
  35. Steering Committee Meeting 2011/06 ‎(45 revisions)
  36. FA uptake and transport proteins ‎(44 revisions)
  37. Workshop - 2011/05 ‎(44 revisions)
  38. Lipid mass spectrometric methods established in LipidomicNet ‎(41 revisions)
  39. CDP-Glycerols (GP13) ‎(41 revisions)
  40. Ceramides - stratum corneum, free extractable - LC-MS - Farwanah et al. ‎(40 revisions)
  41. Steroid hormones ‎(40 revisions)
  42. Cell isolation procedures ‎(40 revisions)
  43. Platelet isolation ‎(40 revisions)
  44. Workshop - 2009/03 ‎(39 revisions)
  45. Glycerophosphocholines (GP01) ‎(38 revisions)
  46. Current events ‎(38 revisions)
  47. Microarray SPPs ‎(38 revisions)
  48. Phosphatidylcholine / Sphingomyelin - ESI-MS/MS - Liebisch et al. ‎(37 revisions)
  49. Downloads ‎(37 revisions)
  50. Granulocyte isolation ‎(36 revisions)
  51. Site Map ‎(34 revisions)
  52. Glycerophosphoinositols (GP06) / phosphates (GP07-09) ‎(33 revisions)
  53. Mass Spectrometry of Lipids SPPs ‎(33 revisions)
  54. Deliverables ‎(33 revisions)
  55. Lipid Class ‎(32 revisions)
  56. Degradation of FA (b-oxidation) ‎(31 revisions)
  57. P01 UHREG ‎(31 revisions)
  58. Affymetrix SPP ‎(31 revisions)
  59. Workshop - 2011/10 ‎(31 revisions)
  60. Task Force II ‎(30 revisions)
  61. WP4 ‎(29 revisions)
  62. Preprocessing and differential expression with CARMAWeb ‎(29 revisions)
  63. Standard Processing Procedures ‎(28 revisions)
  64. Lipidomics technologies ‎(28 revisions)
  65. Oxysterols ‎(27 revisions)
  66. TaqMan SPPs ‎(27 revisions)
  67. Glycerophosphoserines (GP03) ‎(27 revisions)
  68. Tools ‎(26 revisions)
  69. Templates ‎(26 revisions)
  70. Glycerophosphates (GP10) ‎(26 revisions)
  71. Databases ‎(26 revisions)
  72. Work Package Overview ‎(26 revisions)
  73. Sphingoid bases (SP01) ‎(25 revisions)
  74. Workshop - 2008/09 ‎(25 revisions)
  75. Lipid mass spectrometry SOPs deliverable status ‎(25 revisions)
  76. Lysophosphatidylcholine - ESI-MS/MS - Liebisch et al. ‎(25 revisions)
  77. P02 UU ‎(25 revisions)
  78. P15A UBO ‎(25 revisions)
  79. Sphingosine-1-phosphate, Lysophosphatidic acid - LC-MS/MS - Scherer et al. ‎(24 revisions)
  80. Branched chain fatty acids ‎(24 revisions)
  81. Cholesterol sulfate ‎(24 revisions)
  82. LipidomicNet-ENOR workshop program ‎(24 revisions)
  83. Steering Committee Meeting - 01/2012 ‎(24 revisions)
  84. Cholesterol / Cholesterylester - ESI-MS/MS - Liebisch et al. ‎(24 revisions)
  85. Fatty Acid analysis - GCMS ‎(23 revisions)
  86. Available Data ‎(23 revisions)
  87. Regensburg2014 ‎(23 revisions)
  88. Fatty Acids and Conjugates (FA01) ‎(22 revisions)
  89. Kick off meeting - June 2008 ‎(22 revisions)
  90. Steering Committee Meeting - 07/2010 ‎(22 revisions)
  91. Data type taskforces ‎(22 revisions)
  92. P17 UMG-GOE ‎(21 revisions)
  93. Preprocessing of Single Colored Agilent Arrays ‎(21 revisions)
  94. Handling Synopsis Lists ‎(21 revisions)
  95. Adipocyte isolation and cultivation ‎(21 revisions)
  96. Lipid mass spectrometry equipment in LipidomicNet ‎(21 revisions)
  97. BioUML ‎(21 revisions)
  98. Retinoid determination - Gunderson et al. ‎(20 revisions)
  99. Profiling of Phospholipids (Utrecht protocol) ‎(20 revisions)
  100. Roche SPPs ‎(20 revisions)
  101. Erythrocyte isolation ‎(20 revisions)
  102. Resources ‎(19 revisions)
  103. Isoprenoids/Retinoids ‎(19 revisions)
  104. Retinoid determination - Kane et al. ‎(19 revisions)
  105. WP6 ‎(19 revisions)
  106. Links ‎(19 revisions)
  107. Regensburg Chip Hybridization Center ‎(19 revisions)
  108. Bile acid homeostasis an Introduction ‎(19 revisions)
  109. P04 INSERM ‎(19 revisions)
  110. High-Content Imaging SPPs ‎(18 revisions)
  111. Ceramide phosphocholines (sphingomyelins) (SP0301) ‎(18 revisions)
  112. Retinoid determination - Wang et al. ‎(18 revisions)
  113. Workshop - 2010/04 ‎(18 revisions)
  114. Processing Pipeline for TaqMan SPPs ‎(18 revisions)
  115. Leukotrienes (FA0302) ‎(17 revisions)
  116. Steering Committee Meeting - 01/2010 ‎(17 revisions)
  117. Bile acids/-conjugates determination - Tagliacozzi et al. ‎(17 revisions)
  118. Cholesterol ‎(17 revisions)
  119. Epoxyeicosatrienoic acids (FA0308) ‎(17 revisions)
  120. Bile acids/-conjugates determination - Von Eckardstein ‎(17 revisions)
  121. Sterols (ST) determination - Lembcke et al. ‎(16 revisions)
  122. Proteomics SPPs ‎(16 revisions)
  123. Differential Expression with ChipInspector ‎(16 revisions)
  124. Sterols (ST) determination - Mezine et al. ‎(16 revisions)
  125. Task Force I - internal pages ‎(16 revisions)
  126. Bile acids/-conjugates determination - Perwaiz et al. ‎(16 revisions)
  127. Glycerophosphoethanolamines (GP02) ‎(16 revisions)
  128. Bile acids - LC-MS/MS - Scherer et al. ‎(16 revisions)
  129. Lipid standards in the LipidomicNet ‎(16 revisions)
  130. Task Force IV ‎(15 revisions)
  131. Setup of a lipid species database ‎(15 revisions)
  132. Teunissen et al. ‎(15 revisions)
  133. Workshop - 2012/07 ‎(15 revisions)
  134. WP3 ‎(14 revisions)
  135. Training ‎(14 revisions)
  136. Sphingolipid profiling - LC-MS/MS - Scherer et al. ‎(14 revisions)
  137. Sphingolipids (SP) ‎(14 revisions)
  138. P11 BRC HAS ‎(14 revisions)
  139. WP1 ‎(14 revisions)
  140. Monocyte Isolation ‎(14 revisions)
  141. WP2 ‎(14 revisions)
  142. MT 03.03.2010 ‎(13 revisions)
  143. 1st Annual LipidomicNet Steering intern ‎(13 revisions)
  144. Oxysterol-binding proteins ‎(13 revisions)
  145. WP7 ‎(13 revisions)
  146. Contact ‎(13 revisions)
  147. Glycerophospholipids (GP) ‎(13 revisions)
  148. Fatty acid oxidative conversion ‎(13 revisions)
  149. Shorthand notation for Glycerolipids (GL) ‎(13 revisions)
  150. LipidomicNet Library ‎(13 revisions)
  151. RT-PCR SPPs ‎(13 revisions)
  152. Exchange Grants ‎(13 revisions)
  153. Sircar et al. ‎(13 revisions)
  154. P03 CMNS ‎(13 revisions)
  155. Haschke et al. ‎(13 revisions)
  156. P14 UH ‎(13 revisions)
  157. Fatty Acid Profiling GC-MS ‎(13 revisions)
  158. Lipoprotein analysis by FPLC - ESI-MS/MS - Wiesner et al. ‎(13 revisions)
  159. Wiki Roadmap ‎(12 revisions)
  160. P07 UNIGRAZ ‎(12 revisions)
  161. WP5 ‎(12 revisions)
  162. AdditionalGroups ‎(12 revisions)
  163. Eicosanoids (FA03) ‎(12 revisions)
  164. Davies et al. ‎(12 revisions)
  165. Ensembl genes without Agilent Probe ID ‎(12 revisions)
  166. WP8 ‎(12 revisions)
  167. Nomenclature of lipid species ‎(12 revisions)
  168. Skin lipid analysis - HPTLC - Farwanah et al. ‎(12 revisions)
  169. Bile acid quantitation - LC-MS/MS ‎(11 revisions)
  170. Data types and attributes in lipid species databases ‎(11 revisions)
  171. Lipid Storage Genes ‎(11 revisions)
  172. Workshop - 2008/09 - presentations ‎(11 revisions)
  173. Lipid standards used in LipidomicNet - Sterols ‎(11 revisions)
  174. Implementation of Proteomics SPPs ‎(11 revisions)
  175. GENE LIST Glycerophospholipid metabolism ‎(11 revisions)
  176. Docosanoids (FA04) ‎(11 revisions)
  177. P18 BIOBASE ‎(11 revisions)
  178. Task Force VII ‎(11 revisions)
  179. P15B UBO ‎(10 revisions)
  180. Task Force III ‎(10 revisions)
  181. Lipoprotein preparation ‎(10 revisions)
  182. P06 ETHZ ‎(10 revisions)
  183. Lipid standards used in LipidomicNet - Sphingolipids ‎(10 revisions)
  184. P08 UGOT ‎(10 revisions)
  185. MT 15.06.2008 ‎(10 revisions)
  186. P27 JUMC ‎(10 revisions)
  187. Phospholipid metabolism ‎(10 revisions)
  188. Lipoxins (FA0304) ‎(10 revisions)
  189. Task Force V ‎(10 revisions)
  190. PPAR ‎(10 revisions)
  191. Glycerophosphoglycerols (GP04) ‎(10 revisions)
  192. MT 09.07.2008 ‎(10 revisions)
  193. Description of MS methods in databases ‎(10 revisions)
  194. Schwedhelm et al. ‎(9 revisions)
  195. Funding for researchers ‎(9 revisions)
  196. Isoprostanes ‎(9 revisions)
  197. P16 EMBL ‎(9 revisions)
  198. Task Force IX ‎(9 revisions)
  199. Lipid extraction ‎(9 revisions)
  200. Phospholipid class-specific profiling by LC/MS (Utrecht protocol) ‎(9 revisions)
  201. Implementation of TaqMan SPPs ‎(9 revisions)
  202. Processing Pipeline for Proteomics SPPs ‎(9 revisions)
  203. Monoacylglycerophospholipids ‎(9 revisions)
  204. Agilent Feature Extraction ‎(9 revisions)
  205. TF IV 30.09.2008 ‎(9 revisions)
  206. Webex ‎(8 revisions)
  207. P05 LUMC ‎(8 revisions)
  208. Freeze Fracture ‎(8 revisions)
  209. MT 23.07.2008 ‎(8 revisions)
  210. P25 ISB ‎(8 revisions)
  211. MT 03.09.2008 ‎(8 revisions)
  212. Fatty Acyls (FA) ‎(8 revisions)
  213. Project Status Report for Period 2 ‎(8 revisions)
  214. No Access ‎(8 revisions)
  215. Glycerophosphoglycerophosphates (GP05) ‎(8 revisions)
  216. P21 INTEGROMICS ‎(8 revisions)
  217. Prostaglandin quantification - GC-MS ‎(8 revisions)
  218. TF VIII 30.07.2008 ‎(8 revisions)
  219. TF VIII ActionPoints 2010 ‎(7 revisions)
  220. P23 MRC ‎(7 revisions)
  221. Differential Expression using the B-Fabric Analysis tool ‎(7 revisions)
  222. Profiling of Neutral Lipids (Utrecht protocol) ‎(7 revisions)
  223. Lipid standards used in LipidomicNet - Glycerophospholipids ‎(7 revisions)
  224. Implementation of Microarray SPPs ‎(7 revisions)
  225. GC-MS ‎(7 revisions)
  226. Bile acids/-conjugates ‎(7 revisions)
  227. MT 25.06.2008 ‎(7 revisions)
  228. MT 16.07.2008 ‎(7 revisions)
  229. Phosphatidylethanolamine - ESI-MS/MS - Liebisch et al. ‎(7 revisions)
  230. Cell culture from DeMatteis lab ‎(7 revisions)
  231. Fluorescence Microscopy (High-Content Imaging) SPP for the Evotec Opera automated microscope ‎(7 revisions)
  232. TF VII 17.09.2008 ‎(7 revisions)
  233. Processing Pipeline for Microarray SPPs ‎(7 revisions)
  234. Shorthand notation for Glycerophospholipids (GP) ‎(7 revisions)
  235. Sphingosine-1-phosphate quantitation ‎(7 revisions)
  236. Shorthand notation for Sphingolipids (SP) ‎(7 revisions)
  237. MT 10.09.2008 ‎(7 revisions)
  238. Magnetic bead isolation of Mitochondria and following western blot analysis ‎(7 revisions)
  239. MT 10.11.2008 ‎(7 revisions)
  240. Offline nanoESI Phospholipid Profiling - LC-MS/MS ‎(6 revisions)
  241. Glycerolipids (GL) ‎(6 revisions)
  242. High pressure freezing and freeze substitution of cells grown on Aclar discs (Burger lab) ‎(6 revisions)
  243. TF I 21.10.2008 ‎(6 revisions)
  244. TF IV 11.11.2008 ‎(6 revisions)
  245. Fixation of cells with 4% paraformaldehyde ‎(6 revisions)
  246. Analysis of lipid metabolism kinetics by pulse-chase in living cells (Thiele lab) ‎(6 revisions)
  247. P28 JKU ‎(6 revisions)
  248. Press releases ‎(6 revisions)
  249. TF IV 19.08.2008 ‎(6 revisions)
  250. Processing Pipeline for High-Content Imaging SPPs ‎(6 revisions)
  251. Hydroxy/hydroperoxyeicosatetraenoic acids (FA0306) ‎(6 revisions)
  252. Processing Pipeline for Mass Spectrometry of Lipids SPPs ‎(6 revisions)
  253. P12 IEE SAS ‎(6 revisions)
  254. Shorthand notation for Sterols (ST) ‎(6 revisions)
  255. FAQ ‎(5 revisions)
  256. Implementation of High-Content Imaging SPPs ‎(5 revisions)
  257. MT 02.07.2008 ‎(5 revisions)
  258. Cholesterol biosynthesis assay ‎(5 revisions)
  259. Ethics proposals ‎(5 revisions)
  260. Butanolic lipid extraction ‎(5 revisions)
  261. Fixation and permeabilization protocols from DeMAtteis lab ‎(5 revisions)
  262. Discussion on lipid standards in LipidomicNet ‎(5 revisions)
  263. Subcategory: Monoacylglycerophospholipids ‎(5 revisions)
  264. Triglyceride hydrolysis kinetics ‎(5 revisions)
  265. TF VIII 13.08.2008 ‎(5 revisions)
  266. Lipid extraction according to Bligh and Dyer ‎(5 revisions)
  267. Hybridization of labeled RNA to cDNA Microarrays ‎(5 revisions)
  268. Phospholipidosis detection ‎(5 revisions)
  269. Synthesis of PS and formation of PE in the mitochondrial PSDecarboxylation pathway ‎(5 revisions)
  270. Antibodies against lipid droplet proteins ‎(5 revisions)
  271. MT 27.08.2008 ‎(5 revisions)
  272. P20 PROTAGEN ‎(5 revisions)
  273. ApoA-I containing lipoproteins ‎(5 revisions)
  274. Polyketides ‎(5 revisions)
  275. HF diet for mouse feeding ‎(5 revisions)
  276. Lysosomal storage disorders ‎(5 revisions)
  277. Free cholesterol/cholesterol ester distribution ‎(5 revisions)
  278. Lipid extraction using MTBE ‎(4 revisions)
  279. MT 01.10.2008 ‎(4 revisions)
  280. Staining of cells ‎(4 revisions)
  281. TF VII 24.12.2008 ‎(4 revisions)
  282. Processing Pipelines ‎(4 revisions)
  283. Leukocyte populations and platelets ‎(4 revisions)
  284. Ceramide Profiling LC-MS/MS ‎(4 revisions)
  285. Bile acid regulation of drug metabolism ‎(4 revisions)
  286. Megakaryocyte Platelet Synopsis ‎(4 revisions)
  287. SiRNA knock down - A431 cells - 24 well plate - analysis by fluorescence microscopy (Thiele lab) ‎(4 revisions)
  288. Lipoprotein separation by FPLC - Wiesner et al. ‎(4 revisions)
  289. Other hydroxylase pathways ‎(4 revisions)
  290. HTP Image analysis of LD size in differentiated adipocytes ‎(4 revisions)
  291. Membranes ‎(4 revisions)
  292. Glycerophospholipid Profiling - FT-MS ‎(4 revisions)
  293. G-Protein Receptors lipid binding 20110810 ‎(4 revisions)
  294. Phospholipid and neutral lipid droplet staining ‎(4 revisions)
  295. Sphingolipid analysis by mass spectrometry ‎(4 revisions)
  296. MT 24.09.2008 ‎(4 revisions)
  297. P26 WWU ‎(4 revisions)
  298. TF IV 14.10.2008 ‎(4 revisions)
  299. Aminoallyl Labeling of RNA for Microarray Hybridization ‎(4 revisions)
  300. MT 24.12.2008 ‎(4 revisions)
  301. HUVEC isolation and cloning (JUMC) ‎(4 revisions)
  302. Cholesteryl ester synthesis assay ‎(4 revisions)
  303. Metabolism and subcellular compartmentalization of sphingolipids ‎(4 revisions)
  304. Tagged constructs of lipid droplet proteins for imaging ‎(4 revisions)
  305. Project Status Report for Period 1 ‎(4 revisions)
  306. MT 15.10.2008 ‎(4 revisions)
  307. Oxysterol binding assay ‎(4 revisions)
  308. Adipocyte and SVF isolation from mouse adipose tissue ‎(4 revisions)
  309. MT 05.11.2008 ‎(4 revisions)
  310. Phosphatidylethanolamine-based plasmalogens - ESI-MS/MS - Liebisch et al. ‎(4 revisions)
  311. Cardiovascular diseases ‎(4 revisions)
  312. Granulocyte-enrichment ‎(4 revisions)
  313. Shorthand notation for Fatty Acyls (FA) ‎(4 revisions)
  314. Glycerophospholipids analysis by mass spectrometry ‎(4 revisions)
  315. Workshop - 2009/10 - Abstracts ‎(4 revisions)
  316. MT 17.09.2008 ‎(4 revisions)
  317. Genes involved in sphingolipid metabolism ‎(4 revisions)
  318. WP III TF V 05.09.2008 ‎(4 revisions)
  319. PRP-platelet rich plasma ‎(4 revisions)
  320. The “Kennedy pathway” as the majour route of PC and PE synthesis ‎(4 revisions)
  321. Lipid microdomains ‎(4 revisions)
  322. MT 08.10.2008 ‎(4 revisions)
  323. TF VIII 22.10.2008 ‎(4 revisions)
  324. MT 29.10.2008 ‎(4 revisions)
  325. Microarrays ‎(4 revisions)
  326. P13 BABRAHAM ‎(4 revisions)
  327. MT 19.11.2008 ‎(4 revisions)
  328. EU Framework VII project "LipidomicNet" ‎(4 revisions)
  329. WP III TF V 25.11.2008 ‎(4 revisions)
  330. TF IV 28.10.2008 ‎(4 revisions)
  331. Phosphatidylinositol metabolism ‎(4 revisions)
  332. Glycerolipid Profiling - FT-MS ‎(4 revisions)
  333. Thromboxanes (FA0303) ‎(4 revisions)
  334. Immunofluorescence and Bodipy staining of lipid droplets ‎(4 revisions)
  335. Sterols (ST) ‎(3 revisions)
  336. Nuclear receptors ‎(3 revisions)
  337. HMG-CoA reductase assay ‎(3 revisions)
  338. TF IV 05.08.2008 ‎(3 revisions)
  339. First Bioinformatics Workshop ‎(3 revisions)
  340. Shorthand notation for lipid structures derived from mass spectrometry ‎(3 revisions)
  341. MT 10.12.2008 ‎(3 revisions)
  342. Monoradylglycerols ‎(3 revisions)
  343. Glycosphingolipid biosynthesis ‎(3 revisions)
  344. TF VII 01.10.2008 ‎(3 revisions)
  345. TF VII 26.11.2008 ‎(3 revisions)
  346. Total Lipid Profiling LTQ-FT ‎(3 revisions)
  347. Mouse Key Nodes ‎(3 revisions)
  348. Phosphatidylserine - ESI-MS/MS - Liebisch et al. ‎(3 revisions)
  349. Glycosphingolipid degradation ‎(3 revisions)
  350. Implementation of Mass Spectrometry of Lipids SPPs ‎(3 revisions)
  351. Preparation of delipidated FCS (Thiele lab) ‎(3 revisions)
  352. Acidic glycosphingolipids (SP06) ‎(3 revisions)
  353. Secosteroids (ST03) ‎(3 revisions)
  354. Staining of lipid droplets with oil Red O ‎(3 revisions)
  355. TF VII 29.10.2008 ‎(3 revisions)
  356. Alternative bile acid biosynthetic (acidic or sterol 27-hydroxylas) pathway ‎(3 revisions)
  357. MT 14.01.2009 ‎(3 revisions)
  358. Glycosphingolipid metabolism ‎(3 revisions)
  359. Lipoprotein sphingolipids as potential atherogenic factors ‎(3 revisions)
  360. Sterols (ST01) ‎(3 revisions)
  361. TF VII 03.09.2008 ‎(3 revisions)
  362. Glycerophospholipid Profiling - LC-MS/MS ‎(3 revisions)
  363. High throughput workshop ‎(3 revisions)
  364. CAR ‎(3 revisions)
  365. Databases for lipid species ‎(3 revisions)
  366. Steering Committee Meeting Regensburg July 2009 ‎(3 revisions)
  367. Purification LDs from mouse adipocytes ‎(3 revisions)
  368. TF VII 06.08.2008 ‎(3 revisions)
  369. Teststartpage ‎(3 revisions)
  370. MT 03.12.2008 ‎(3 revisions)
  371. Implementation of Standard Processing Procedures ‎(3 revisions)
  372. Fatty Acyls analysis by mass spectrometry ‎(3 revisions)
  373. UK ‎(3 revisions)
  374. SiRNA knock down - HuH7 cells - 24 well plate - analysis by fluorescence microscopy (Thiele lab) ‎(3 revisions)
  375. Steroid conjugates (ST05) ‎(3 revisions)
  376. TF VIII 19.11.2008 ‎(3 revisions)
  377. MT 26.11.2008 ‎(3 revisions)
  378. The classic bile acid biosynthetic (neutral) pathway ‎(3 revisions)
  379. TaqMan Arrays ‎(3 revisions)
  380. Task Force VI ‎(3 revisions)
  381. Lipid extraction according to modified Folch ‎(3 revisions)
  382. Sphingolipids and apoptosis ‎(3 revisions)
  383. TF VII 15.10.2008 ‎(3 revisions)
  384. Signalling pathways induced by sphingolipids ‎(3 revisions)
  385. MT 17.12.2008 ‎(3 revisions)
  386. Plant sterols ‎(3 revisions)
  387. WP III TF V 14.10.2008 ‎(3 revisions)
  388. Lipid extraction for TLC (Chloroform-Methanol, Thiele lab) ‎(3 revisions)
  389. SVF human cells isolation and culture (JUMC) ‎(3 revisions)
  390. Sphingolipids and cell differentiation ‎(3 revisions)
  391. Fatty acid remodelling ‎(3 revisions)
  392. Lipid probes ‎(3 revisions)
  393. TF IV 25.11.2008 ‎(3 revisions)
  394. Sterol analysis by mass spectrometry ‎(3 revisions)
  395. Non targeted Lipid Profiling LC-FT-MS/MS ‎(3 revisions)
  396. International lipid meetings ‎(3 revisions)
  397. Sphingolipids and cell migration and adhesion ‎(3 revisions)
  398. LXR ‎(3 revisions)
  399. Bile acids and derivatives (ST04) ‎(3 revisions)
  400. Lipases and LCAT ‎(3 revisions)
  401. ApoB containing lipoproteins ‎(3 revisions)
  402. MT 20.08.2008 ‎(3 revisions)
  403. P22 UOXF.H7 ‎(3 revisions)
  404. Task Force VIII phone conferences ‎(3 revisions)
  405. Sphingolipids and vascular tone regulation ‎(3 revisions)
  406. TF VII 20.08.2008 ‎(3 revisions)
  407. MT 21.01.2009 ‎(3 revisions)
  408. Prenol Lipids ‎(2 revisions)
  409. Absorption and lipoprotein transport of sphingomyelin ‎(2 revisions)
  410. Cholesterol analysis - GCMS ‎(2 revisions)
  411. Workshop Graz 2009-10-26 27 ‎(2 revisions)
  412. MT 22.10.2008 ‎(2 revisions)
  413. Prenylation ‎(2 revisions)
  414. Acid ceramidase assay ‎(2 revisions)
  415. Staining of lipid droplets with Nile red and BODIPY 493/503 ‎(2 revisions)
  416. TF IV 09.12.2008 ‎(2 revisions)
  417. First Bioinformatics Workshop, Sept 2008 ‎(2 revisions)
  418. Agilent not mapped probes ‎(2 revisions)
  419. MT 13.08.2008 ‎(2 revisions)
  420. Steering Committee Meeting Regensburg, July 2009 ‎(2 revisions)
  421. FAS II ‎(2 revisions)
  422. Workshop Graz 2009-10-26 27 Abstracts ‎(2 revisions)
  423. Templates for new articles ‎(2 revisions)
  424. Bile acid regulation of glucose metabolism ‎(2 revisions)
  425. First Bioinformatics Workshop - presentations ‎(2 revisions)
  426. SiRNA knock down - A431 cells - 24 well plate - biochemical analysis (Thiele lab) ‎(2 revisions)
  427. FATP ‎(2 revisions)
  428. TF VIII 03.12.2008 ‎(2 revisions)
  429. Glycerophosphatidylinositol (GPI)-anchor ‎(2 revisions)
  430. Templates for presentations ‎(2 revisions)
  431. Bile acid regulation of lipid metabolism ‎(2 revisions)
  432. Events ‎(2 revisions)
  433. SiRNA knock down - HeLa cells - 24 well plate - analysis by fluorescence microscopy (Thiele lab) ‎(2 revisions)
  434. TF VIII 08.10.2008 ‎(2 revisions)
  435. TF IV 16.09.2008 ‎(2 revisions)
  436. High throughput workshop - March 2009 ‎(2 revisions)
  437. SiRNA knock down - HeLa cells - 24 well plate - biochemical analysis (Thiele lab) ‎(2 revisions)
  438. Discussion on the mass spectrometric analysis of triglyceride rich samples ‎(2 revisions)
  439. New page ‎(2 revisions)
  440. FXR ‎(2 revisions)
  441. Glycosylglycerophospholipids (GP14) ‎(2 revisions)
  442. Purification LDs from mouse hepatocytes ‎(2 revisions)
  443. Synthesis and metabolism of straight chain fatty acids ‎(2 revisions)
  444. TF VII 10.12.2008 ‎(2 revisions)
  445. Kerstin Leuthaeuser-Jaschinski ‎(2 revisions)
  446. Shorthand notation - General rules ‎(2 revisions)
  447. Fixed/permeabilized cultured cells - BD Pathway Bioimager 855 (JUMC) ‎(2 revisions)
  448. Ganglioside extraction ‎(2 revisions)
  449. Lipid extraction according to Folch ‎(2 revisions)
  450. Mass spectrometric profiling of free extractable stratum corneum ceramides by means of LC/APCI-MS ‎(2 revisions)
  451. TF VII 12.11.2008 ‎(2 revisions)
  452. MT 06.08.2008 ‎(2 revisions)
  453. Events: External ‎(2 revisions)
  454. TF IV 20.01.2009 ‎(2 revisions)
  455. Flow cytometry ‎(2 revisions)
  456. SiRNA knock down - HuH7 cells - 24 well plate - biochemical analysis (Thiele lab) ‎(2 revisions)
  457. TF VIII 22.04.2009 ‎(2 revisions)
  458. P19 ZORA ‎(2 revisions)
  459. Phosphosphingolipids (SP03) ‎(2 revisions)
  460. ROR ‎(2 revisions)
  461. 2nd Steering Committee Meeting Regensburg ‎(2 revisions)
  462. Cytotoxicity assay (JUMC) ‎(2 revisions)
  463. TF IV 23.12.2008 ‎(2 revisions)
  464. Visualization of fixed/permeabilized cultured cells (JUMC) ‎(2 revisions)
  465. Antibodies from DeMatteis lab ‎(2 revisions)
  466. Steroids (ST02) ‎(2 revisions)
  467. FXR regulation of bile acid synthesis, transport and absorption ‎(2 revisions)
  468. Germany ‎(2 revisions)
  469. Inositol phosphates ‎(2 revisions)
  470. Mass spectrometry ‎(2 revisions)
  471. PXR/SXR ‎(2 revisions)
  472. Thin layer chromatography (Thiele Lab) ‎(2 revisions)
  473. Images acquisition and analysis from De Matteis laboratory ‎(2 revisions)
  474. Cell proliferation BrdU (JUMC) ‎(2 revisions)
  475. TF VIII 28.01.2009 ‎(2 revisions)
  476. ACAT in vitro assay ‎(2 revisions)
  477. Lipid extraction from yeast ‎(2 revisions)
  478. Saccharolipids ‎(2 revisions)
  479. Lysosomal lipid-binding proteins: purification ‎(2 revisions)
  480. MT 30.07.2008 ‎(2 revisions)
  481. Mechanisms of bile acid feedback inhibition of gene transcription ‎(2 revisions)
  482. Palmitoylation ‎(2 revisions)
  483. Data Management Training Workshop Cambridge 2010 ‎(2 revisions)
  484. Fluorescent microscopy of neutral lipids in yeast ‎(2 revisions)
  485. Imaging of lipid droplets, nuclei and cytoplasm in the 96-well format (Thiele lab) ‎(2 revisions)
  486. Sterols ‎(2 revisions)
  487. Nuclear receptor regulation of bile acid synthesis ‎(2 revisions)
  488. TF IV 02.09.2008 ‎(2 revisions)
  489. Glycerophosphoinositolglycans (GP15) ‎(2 revisions)
  490. Hepatocyte and Stellate cell isolation from mouse liver ‎(2 revisions)
  491. Glyceropyrophosphates (GP11) ‎(2 revisions)

View (previous 500) (next 500) (20 | 50 | 100 | 250 | 500)

Views
Personal tools